Effects of Cornelian Cherry Supplementation in Patients With Metabolic Syndrome

NCT07739602 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2026-07-31

No results posted yet for this study

Summary

This randomized, double-blind, placebo-controlled, parallel-group study evaluated the effects of six-month oral supplementation with Cornus mas fruit lyophilizate in patients with metabolic syndrome. Participants were assigned to receive either 8 g of Cornus mas fruit lyophilizate once daily or a matching placebo. Ophthalmic assessments included best-corrected visual acuity, slit-lamp examination, dilated fundus examination, applanation tonometry, and Doppler ultrasonography of the ophthalmic, central retinal, and posterior ciliary arteries. Cardiometabolic and biochemical parameters were also assessed at baseline and after 3 and 6 months of supplementation.

Conditions

Interventions

DIETARY_SUPPLEMENT

Placebo

A matching placebo formulation containing potato starch and sugar but no Cornus mas fruit lyophilizate, administered orally once daily for 6 months as a preparation made into a jelly.

DIETARY_SUPPLEMENT

Cornus mas Fruit Lyophilizate

A dietary supplement containing 8 g of lyophilized whole Cornus mas L. fruit, administered orally once daily for 6 months as a powder or granulate formulation prepared as a jelly.

Sponsors & Collaborators

  • Wroclaw Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-17
Primary Completion
2026-06-25
Completion
2026-06-25

Countries

  • Poland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07739602 on ClinicalTrials.gov